0001144204-19-029894.txt : 20190605 0001144204-19-029894.hdr.sgml : 20190605 20190605163141 ACCESSION NUMBER: 0001144204-19-029894 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190603 FILED AS OF DATE: 20190605 DATE AS OF CHANGE: 20190605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Li Ting CENTRAL INDEX KEY: 0001759813 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35853 FILM NUMBER: 19880058 MAIL ADDRESS: STREET 1: C/O BIOSTAGE, INC. STREET 2: 84 OCTOBER HILL RD. CITY: HOLLISTON STATE: MA ZIP: 01746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biostage, Inc. CENTRAL INDEX KEY: 0001563665 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455210462 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: (774) 233-7300 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 FORMER COMPANY: FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc. DATE OF NAME CHANGE: 20121204 4 1 tv523167_form4.xml FORM 4 X0306 4 2019-06-03 0 0001563665 Biostage, Inc. BSTG 0001759813 Li Ting C/O BIOSTAGE, INC. 84 OCTOBER HILL ROAD, SUITE 11 HOLLISTON MA 01746 1 0 0 0 Stock Option (right to buy) 2.90 2019-06-03 4 A 0 10364 0 A 2029-06-03 Common Stock, par value $0.01 per share 10364 10364 D Stock Option (right to buy) 2.90 2019-06-03 4 A 0 8411 0 A 2029-06-03 Common Stock, par value $0.01 per share 8411 18775 D Stock Option (right to buy) 2.90 2019-06-03 4 A 0 1270 0 A 2019-06-03 2029-06-03 Common Stock, par value $0.01 per share 1270 20045 D This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 3, 2019, December 3, 2019, March 3, 2020, and June 3, 2020. This Stock Option was granted in lieu of 2019 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2019, September 30, 2019, and December 31, 2019. This Stock Option was granted in lieu of 2018 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer. This form has been signed under power of attorney. /s/ Chad Porter, by power of attorney 2019-06-05